BRAIN, FOCUS & MOOD RESEARCH

Semax

A Russian nootropic peptide studied for focus, memory, and recovery from neurological stress.

Semax is a synthetic peptide developed in Russia, where it has a long clinical-use history for cognitive and neuroprotective applications. It is studied for focus, memory, and recovery from neurological stress, and its mechanism is well described: it raises BDNF, the growth factor that supports the formation of new brain-cell connections.

ACTH(4-10) AnalogueNootropicNeuroprotectiveBDNF Upregulation

Why BLP features Semax

Included because it has decades of documented Russian clinical use—material foreign evidence—alongside a described BDNF-based mechanism and a consistent research-use history. Its foreign clinical foundation distinguishes it from newer, unstudied analogues.

Mechanism

Raises BDNF and its receptor—the growth-factor system associated with the formation of new brain cells and connections.

Increases dopamine and serotonin activity, and boosts the body's own enkephalins along with the brain's capacity to rewire.

Crosses the blood-brain barrier rapidly.

WHAT THE RESEARCH MEASURED

Research findings

Findings describe study outcomes, not expected personal results.

Human research findings

  • Russian clinical research reports improved focus and cognitive performance.
  • Reported improved memory and learning speed, and reduced anxiety and mental fatigue.
  • Reported faster recovery from neurological stress in study settings.
  • Very mild tolerability; rare nasal irritation with intranasal use.

Preclinical findings

  • BDNF/TrkB mechanism characterized in neuroscience research.
  • Neuroprotective effects documented in stroke and injury models.

Regulatory status

Semax is used clinically in Russia and some other countries but is not FDA-approved. Sold and offered strictly for laboratory and research use.